A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer
Clinical trial NCT02051751 · COMPLETED
Trial details
- NCT number
- NCT02051751
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-05
- Primary completion
- 2016-08-19
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.